News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
642,052 Results
Type
Article (61137)
Company Profile (70)
Press Release (580845)
Section
Business (173499)
Career Advice (2727)
Deals (32396)
Drug Delivery (96)
Drug Development (76769)
Employer Resources (150)
FDA (14907)
Job Trends (13866)
News (304525)
Policy (28895)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (2887)
Academic (2)
Accelerated approval (5)
Adcomms (22)
Allergies (83)
Alliances (43045)
ALS (82)
Alzheimer's disease (1299)
Antibody-drug conjugate (ADC) (95)
Approvals (14920)
Artificial intelligence (242)
Autoimmune disease (18)
Automation (13)
Bankruptcy (289)
Best Places to Work (10853)
BIOSECURE Act (15)
Biosimilars (98)
Biotechnology (51)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (251)
Cancer (1949)
Cardiovascular disease (152)
Career advice (2308)
Career pathing (32)
CAR-T (142)
Cell therapy (400)
Cervical cancer (20)
Clinical research (62214)
Collaboration (723)
Compensation (284)
Complete response letters (20)
COVID-19 (2566)
CRISPR (38)
C-suite (228)
Cystic fibrosis (98)
Data (1938)
Decentralized trials (2)
Denatured (25)
Depression (38)
Diabetes (233)
Diagnostics (6124)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (106)
Drug pricing (95)
Drug shortages (23)
Duchenne muscular dystrophy (78)
Earnings (59710)
Editorial (34)
Employer branding (18)
Employer resources (132)
Events (93688)
Executive appointments (680)
FDA (16025)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (692)
Gene editing (101)
Generative AI (19)
Gene therapy (272)
GLP-1 (641)
Government (4431)
Grass and pollen (5)
Guidances (46)
Healthcare (18196)
Huntington's disease (18)
IgA nephropathy (22)
Immunology and inflammation (96)
Indications (25)
Infectious disease (2689)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (86)
Interviews (526)
IPO (14762)
IRA (38)
Job creations (3409)
Job search strategy (1941)
Kidney cancer (9)
Labor market (26)
Layoffs (489)
Leadership (19)
Legal (6422)
Liver cancer (64)
Lung cancer (279)
Lymphoma (126)
Machine learning (4)
Management (53)
Manufacturing (243)
MASH (56)
Medical device (12609)
Medtech (12614)
Mergers & acquisitions (18153)
Metabolic disorders (582)
Multiple sclerosis (70)
NASH (13)
Neurodegenerative disease (77)
Neuropsychiatric disorders (23)
Neuroscience (1766)
NextGen: Class of 2025 (6373)
Non-profit (4313)
Northern California (2213)
Now hiring (11)
Obesity (299)
Opinion (227)
Ovarian cancer (68)
Pain (84)
Pancreatic cancer (73)
Parkinson's disease (130)
Partnered (20)
Patents (205)
Patient recruitment (98)
Peanut (50)
People (59338)
Pharmaceutical (21)
Pharmacy benefit managers (15)
Phase I (19569)
Phase II (27449)
Phase III (20058)
Pipeline (1002)
Podcasts (55)
Policy (103)
Postmarket research (2468)
Preclinical (8304)
Press Release (67)
Prostate cancer (93)
Psychedelics (27)
Radiopharmaceuticals (247)
Rare diseases (341)
Real estate (5978)
Recruiting (61)
Regulatory (19964)
Reports (33)
Research institute (2394)
Resumes & cover letters (405)
Rett syndrome (4)
RNA editing (3)
RSV (33)
Schizophrenia (63)
Series A (122)
Series B (80)
Service/supplier (9)
Sickle cell disease (50)
Southern California (1954)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (28)
Startups (3336)
State (1)
Stomach cancer (9)
Supply chain (47)
Tariffs (7)
The Weekly (28)
United States (19579)
Vaccines (634)
Venture capitalists (29)
Webinars (12)
Weight loss (192)
Women's health (30)
Worklife (18)
Date
Today (51)
Last 7 days (626)
Last 30 days (2449)
Last 365 days (30908)
2025 (7857)
2024 (32268)
2023 (36327)
2022 (46606)
2021 (51559)
2020 (50709)
2019 (44762)
2018 (34054)
2017 (30708)
2016 (30053)
2015 (35432)
2014 (28371)
2013 (24944)
2012 (26202)
2011 (26449)
2010 (24919)
Location
Africa (871)
Alabama (50)
Alaska (6)
Arizona (164)
Arkansas (14)
Asia (37917)
Australia (6828)
California (5051)
Canada (1719)
China (439)
Colorado (230)
Connecticut (242)
Delaware (123)
Europe (88148)
Florida (773)
Georgia (189)
Idaho (56)
Illinois (511)
India (24)
Indiana (266)
Iowa (8)
Japan (133)
Kansas (92)
Kentucky (23)
Louisiana (9)
Maine (60)
Maryland (780)
Massachusetts (3675)
Michigan (210)
Minnesota (320)
Mississippi (2)
Missouri (82)
Montana (29)
Nebraska (23)
Nevada (51)
New Hampshire (60)
New Jersey (1512)
New Mexico (29)
New York (1487)
North Carolina (915)
North Dakota (8)
Northern California (2213)
Ohio (182)
Oklahoma (15)
Oregon (35)
Pennsylvania (1129)
Puerto Rico (10)
Rhode Island (25)
South America (1174)
South Carolina (15)
South Dakota (1)
Southern California (1954)
Tennessee (90)
Texas (779)
Utah (157)
Virginia (128)
Washington D.C. (45)
Washington State (479)
West Virginia (3)
Wisconsin (53)
642,052 Results for "university of notre dame".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Kraig Biocraft Laboratories Creates Synergy by Onboarding Key Elements and Scientists from the University of Notre Dame Spider Silk Research Operations
Kraig Biocraft Laboratories, Inc. today announced that it hired key scientists from the University of Notre Dame (“UND”) spider silk research lab following the retirement of Dr. Malcolm Fraser, Professor Emeritus.
October 12, 2023
·
3 min read
Horizon Therapeutics plc Makes Founding Gift to Support the University of Notre Dame’s Patient Advocacy Initiative
Horizon Therapeutics plc (Nasdaq: HZNP) today announced it has made a founding, five-year gift to establish the University of Notre Dame’s Patient Advocacy Initiative in the College of Science.
September 16, 2022
·
5 min read
Press Releases
Avantor® Appoints Dame Louise Makin, DBE, Ph.D., to its Board of Directors
November 7, 2024
·
3 min read
Press Releases
Tanke Biosciences Corp Announces Appointment of Vincent Renz as Chief Executive Officer and Member of the Board of Directors
February 13, 2025
·
3 min read
Deals
University of Notre Dame Increases Equity Position in Kraig Biocraft Laboratories
Kraig Biocraft Laboratories, Inc., the leading developer of spider silk based fibers, announces that it has signed an agreement with the University of Notre Dame, which increases the University’s equity position in Kraig Labs.
March 13, 2019
·
2 min read
Press Releases
Propel Health Welcomes Christopher Blanco as New Chief Financial Officer
January 16, 2025
·
1 min read
Press Releases
Crescent Biopharma Appoints Joshua Brumm as Chief Executive Officer and Expands Leadership Team to Advance Pipeline of Potentially Best-in-Class Oncology Therapeutics
April 3, 2025
·
9 min read
Press Releases
USANA Appoints New Chief Scientific Officer
January 22, 2025
·
3 min read
Press Releases
SynerFuse™ Proof-of-Concept Study Completed
March 4, 2025
·
8 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
1 of 64,206
Next
